PureSilk Shave Gel (Pfizer) – Product Safety Issue (1996)
Check Your Product
According to the U.S. Consumer Product Safety Commission (CPSC)
Product
PureSilk Shave Gel for women
Brand
Pfizer
Lot Codes / Batch Numbers
Not specified in CPSC notice. Check official source for details.
Pfizer is recalling PureSilk Shave Gel for women. The hazard is: Laceration. Based on CPSC recall notice.
Summary derived from CPSC notice
The following details were not provided by CPSC: remedy information, UPC codes.
Reason for Recall
As stated by CPSC
Shave Gel Recalled by Pfizer NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE CONTACT: July 2, 1996 (301) 504-7908 Release # 96-157 CPSC and Pfizer Announce Shave Gel Recall WASHINGTON, D.C. - In cooperation with the U.S. Consumer Product Safety Commission (CPSC), the Consumer Health Care Group of Pfizer Inc. is announcing a voluntary recall of cans of PureSilk Shave Gel for women sold between October 1995 and June 1996. The inner liner of the can may corrode, and as a result the can may rupture, which could propel a plastic component or the gel from the can. Consumers could be injured by sharp edges of the ruptured can or by the plastic component. Pfizer is aware of 10 incidents of the cans rupturing. No injuries have been reported. Drug, grocery, and cosmetic stores sold more than 500,000 purple, seven-ounce cans of the shaving gel nationwide for between $2 and $2.50 a can. This recall does not affect the cream product for women sold under the name PureSilk Shave Cream. Consumers should stop using the shave gel immediately and discharge the shaving gel to reduce pressure within the can. Consumers should record the product's lot number, which is printed on the bottom of the container, then discard the shave gel can. To receive a free replacement certificate or a refund, consumers should send their name and address, with the container lot number, to Pfizer Consumer Health Care - Consumer Relations Dept., 235 East 42nd Street, New York, N.Y. 10017-5755. For more information, consumers should call Pfizer at (800) 723-7529. Media inquiries should be directed to Brian McGlynn or Robert Fauteux at (212) 573-7900.
Reported concern (CPSC)
Laceration
Recommended Action
Per CPSC guidance
The CPSC advises consumers to stop using the product. Contact the manufacturer or return the product to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Consumer Product Safety Commission (CPSC) directly.
View official CPSC recall noticePage updated: Jan 6, 2026